M Pharmaceutical Inc. (DB:T3F1) intends to pursue acquisitions. The Company is undertaking a non-brokered private placement of up to $0.75 million. First Sahara intends to use the proceeds for general working capital, including the review of possible acquisitions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% |
|
-.--% | +9,900.00% |
2018 | James Thompson to Assume the Position of President and Chief Executive Officer of Callitas Health Inc | CI |
2018 | Callitas Health Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 4.53K | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- MPHMF Stock
- News Callitas Health Inc.
- First Sahara Mulls Acquisitions